Wave Life Sciences Ltd.
Wave Life Sciences Ltd. (WVE): 5 pipeline candidates · ~28 mo cash runway · 6 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
27.7 months
D/E 0.14 · 4% dilution
Lead: Phase 1/Phase 2
5 candidates
N/A
4 buys · 8 sells (180d)
A transparent, data-derived signal for Wave Life Sciences Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.1B
Cash
$544.6M
Quarterly Burn
$59.6M
Runway
27.7 mo
Revenue
$38.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
233
Total value held
$1.09B
| Holder | Shares | Value |
|---|---|---|
| ra capital management, l.p. | 26,975,505 | $195.6M |
| blackrock, inc. | 14,117,412 | $102.4M |
| maverick capital ltd | 11,317,399 | $82.1M |
| driehaus capital management llc | 5,431,021 | $39.4M |
| federated hermes, inc. | 5,317,457 | $38.6M |
| fmr llc | 5,192,761 | $37.6M |
| 683 capital management, llc | 4,900,000 | $35.5M |
| primecap management co/ca/ | 4,832,952 | $35.0M |
| m28 capital management lp | 4,588,284 | $33.3M |
| state street corp | 3,674,033 | $26.6M |
Showing top 10 of 233 institutional holders of Wave Life Sciences Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Wave Life Sciences Ltd.'s pipeline?
Wave Life Sciences Ltd. (WVE) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Wave Life Sciences Ltd.'s lead drug candidate?
Wave Life Sciences Ltd.'s most advanced tracked candidate is WVE-003 (Phase 1/Phase 2) for Huntington's disease (HD).
What is Wave Life Sciences Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Wave Life Sciences Ltd. has approximately 27.7 months of cash runway.
What is Wave Life Sciences Ltd.'s market capitalization?
Wave Life Sciences Ltd.'s market capitalization is approximately $1.1B.
Who is the CEO of Wave Life Sciences Ltd.?
Dr. Paul B. Bolno M.B.A., M.D. is the chief executive officer of Wave Life Sciences Ltd. (WVE).
Get the full picture on Wave Life Sciences Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.